Esperion Therapeutics | DEF 14A: Definitive information statements
Apr 11 16:26 ET
Esperion Therapeutics | ARS: Annual Report to Security Holders
Apr 11 16:21 ET
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Koenig Sheldon L.
Mar 15 22:17 ET
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warren Eric
Mar 15 22:17 ET
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Foody Joanne M.
Mar 15 16:42 ET
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Halladay Benjamin
Mar 15 16:37 ET
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Looker Benjamin
Mar 15 16:37 ET
Esperion Therapeutics | 10-K: Annual report
Feb 27 09:21 ET
Esperion Therapeutics | 8-K: Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 27 07:25 ET
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(0%),Heights Capital Management, Inc.(0%)
Feb 14 14:19 ET
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Two Seas Capital LP(6.8%),Two Seas Capital GP LLC(6.8%), etc.
Feb 14 10:52 ET
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
Feb 14 08:46 ET
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cubist Systematic Strategies, LLC(0.2%),Steven A. Cohen(0.2%), etc.
Feb 14 06:16 ET
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.52%)
Feb 13 22:53 ET
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Feb 9 16:33 ET
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(5.1%),Biotech Target N.V. N/A(5.1%)
Jan 24 15:50 ET
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(3.7%),Biotech Target N.V. N/A(3.7%)
Jan 24 15:25 ET
Esperion Therapeutics | 8-K: Current report
Jan 22 00:00 ET
Esperion Therapeutics | 424B5: Prospectus
Jan 22 00:00 ET
Esperion Therapeutics | 8-K: Current report
Jan 18 00:00 ET
No Data
No Data